Showing results (41-50 of 49) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Cardiovascular & Hematological Agents in Medicinal Chemistry|March 10, 2010
Cancer treatment-induced cardiotoxicity: a cardiac stem cell disease?Lucia Prezioso, Silvia Tanzi, Federica Galaverna, et al.Journal of Clinical Microbiology|September 7, 2022
Effective Rapid Diagnosis of Bacterial and Fungal Bloodstream Infections by T2 Magnetic Resonance Technology in the Pediatric PopulationBarbara Lucignano, Valeria Cento, Marilena Agosta, et al.European Journal of Haematology|July 23, 2021
Pre-transplant minimal residual disease assessment and transplant-related factors predict the outcome of acute myeloid leukemia patients undergoing allogeneic stem cell transplantationFabio Guolo, Carmen Di Grazia, Paola Minetto, et al.Bone Marrow Transplantation|December 8, 2020
Use of letermovir in off-label indications: Infectious Diseases Working Party of European Society of Blood and Marrow Transplantation retrospective studyJan Styczyński, Gloria Tridello, Alienor Xhaard, et al.Haematologica|May 30, 2024
Mucosal-associated invariant T cells are functionally impaired in pediatric and young adult patients following allogeneic hematopoietic stem cell transplantation and their recovery correlates with clinical outcomesFederica Galaverna, Sara Flamini, Carmen Dolores De Luca, et al.Blood|September 22, 2023
TCRαβ/CD19 cell-depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: updated final analysisPietro Merli, Mattia Algeri, Federica Galaverna, et al.Open Forum Infectious Diseases|May 5, 2025
The Changing Impact of Human Cytomegalovirus Serology and Infection on Patient Outcome After Allogeneic Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey in the Era of Letermovir ProphylaxisCorrado Girmenia, Patrizia Chiusolo, Giovanni Marsili, et al.Journal of Clinical Medicine|March 10, 2022
Consensus on COVID-19 Vaccination in Pediatric Oncohematological Patients, on Behalf of Infectious Working Group of Italian Association of Pediatric Hematology OncologySimone Cesaro, Paola Muggeo, Daniele Zama, et al.The New England Journal of Medicine|April 5, 2023
GD2-CART01 for Relapsed or Refractory High-Risk NeuroblastomaFrancesca Del Bufalo, Biagio De Angelis, Ignazio Caruana, et al.Pageof 5